Literature DB >> 28670396

Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism.

Chunyan Weng1, Zhijie Shen1, Xiaobo Li1, Weihong Jiang1, Liping Peng1, Hong Yuan1, Kan Yang1, Jiangang Wang1.   

Abstract

BACKGROUND: Obesity-induced hypertension (OIH) has a high morbidity and mortality, and its prevention and treatment has been a major challenge in clinical practice. Chemerin is a newly discovered adipokine closely related to OIH.
METHODS: Male Wistar rats (8W) were divided into either a high-fat diet or a regular diet group. Body weight and blood pressure were measured every two weeks. After 20 weeks, serum, adipose tissue and aortic arteries were collected. Arterial tensions were detected; Immunohistochemistry, ELISA and Western blotting were used to detect the expression of chemerin, CMKLR1, Rock2 and P-MYPT1 in the aorta and perivascular adipose tissues.
RESULTS: After 4 weeks, the body weight, systolic blood pressure, diastolic blood pressure and mean arterial pressure were all significantly higher in the high-fat diet group (P<0.05). There was no significant difference in serum chemerin concentration between the OIH group and the control group. However, chemerin and CMKLR1 protein expression was higher in aortic arteries and perivascular adipose tissues of the OIH group (P<0.05). The arterial tension induced by chemerin 9 (1 μM) and the expression of Rock2 and P-MYPT1 were higher in the OIH group (P<0.05).
CONCLUSION: OIH positively correlated with chemerin in tissues but not serum. Arterial tension was increased by chemerin 9. Rock2/P-MYPT1 might be involved in the pathogenesis of increased vascular tone in OIH rats.

Entities:  

Keywords:  CMKLR1; Obesity-induced hypertension; chemerin

Year:  2017        PMID: 28670396      PMCID: PMC5489908     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  21 in total

Review 1.  Mechanisms linking obesity to hypertension.

Authors:  J A N Dorresteijn; F L J Visseren; W Spiering
Journal:  Obes Rev       Date:  2011-08-10       Impact factor: 9.213

2.  Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.

Authors:  Theodore A Kotchen
Journal:  Am J Hypertens       Date:  2010-08-12       Impact factor: 2.689

3.  Distinct pathways of Ca(2+) sensitization in porcine coronary artery: effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca(2+).

Authors:  K Nobe; R J Paul
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

4.  The adipokine chemerin augments vascular reactivity to contractile stimuli via activation of the MEK-ERK1/2 pathway.

Authors:  N S Lobato; K B Neves; F P Filgueira; Z B Fortes; M H C Carvalho; R C Webb; A M Oliveira; R C Tostes
Journal:  Life Sci       Date:  2012-04-13       Impact factor: 5.037

Review 5.  Chemerin: A comprehensive review elucidating the need for cardiovascular research.

Authors:  David J Ferland; Stephanie W Watts
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

6.  Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?

Authors:  Karla Bianca Neves; Núbia S Lobato; Rhéure Alves Moreira Lopes; Fernando P Filgueira; Camila Ziliotto Zanotto; Ana Maria Oliveira; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2014-07       Impact factor: 6.124

7.  Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism.

Authors:  Kerry B Goralski; Tanya C McCarthy; Elyisha A Hanniman; Brian A Zabel; Eugene C Butcher; Sebastian D Parlee; Shanmugam Muruganandan; Christopher J Sinal
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

8.  Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men.

Authors:  Abbas Saremi; Nader Shavandi; Mohammad Parastesh; Hassan Daneshmand
Journal:  Asian J Sports Med       Date:  2010-09

9.  Chemerin and adiponectin contribute reciprocally to metabolic syndrome.

Authors:  Sang Hui Chu; Mi Kyung Lee; Ki Yong Ahn; Jee-Aee Im; Min Soo Park; Duk-Chul Lee; Justin Y Jeon; Ji Won Lee
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox.

Authors:  Karla Bianca Neves; Aurelie Nguyen Dinh Cat; Rheure Alves Moreira Lopes; Francisco Jose Rios; Aikaterini Anagnostopoulou; Nubia Souza Lobato; Ana Maria de Oliveira; Rita C Tostes; Augusto C Montezano; Rhian M Touyz
Journal:  Hypertension       Date:  2015-07-06       Impact factor: 10.190

View more
  15 in total

Review 1.  Novel Targets for Hypertension Drug Discovery.

Authors:  Lokesh Kumar Bhatt; Ishant Selokar; Dezaree Raut; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2021-03-30       Impact factor: 5.369

2.  Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions.

Authors:  David J Ferland; Emma D Flood; Hannah Garver; Steve T Yeh; Stanley Riney; Adam E Mullick; Gregory D Fink; Stephanie W Watts
Journal:  Physiol Genomics       Date:  2019-10-07       Impact factor: 3.107

3.  Parental Dietary Protein Source and the Role of CMKLR1 in Determining the Severity of Dahl Salt-Sensitive Hypertension.

Authors:  Justine M Abais-Battad; Hayley Lund; Daniel J Fehrenbach; John Henry Dasinger; Ammar J Alsheikh; David L Mattson
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 4.  The role of adipose tissue in cardiovascular health and disease.

Authors:  Evangelos K Oikonomou; Charalambos Antoniades
Journal:  Nat Rev Cardiol       Date:  2019-02       Impact factor: 32.419

5.  Novel Adipose Tissue Targets to Prevent and Treat Atherosclerosis.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  Handb Exp Pharmacol       Date:  2022

6.  Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARγ.

Authors:  Xiaojing Lin; Yanan Yang; Jing Qu; Xiaohui Wang
Journal:  Nutr Metab (Lond)       Date:  2019-03-05       Impact factor: 4.169

7.  Chemerin as a Driver of Hypertension: A Consideration.

Authors:  David J Ferland; Adam E Mullick; Stephanie W Watts
Journal:  Am J Hypertens       Date:  2020-11-03       Impact factor: 2.689

8.  Alpha-lipoic acid could attenuate the effect of chemerin-induced diabetic nephropathy progression.

Authors:  Hong Zhang; Jiawei Mu; Jinqiu Du; Ying Feng; Wenhui Xu; Mengmeng Bai; Huijuan Zhang
Journal:  Iran J Basic Med Sci       Date:  2021-08       Impact factor: 2.699

Review 9.  Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus.

Authors:  Monika Ruszała; Magdalena Niebrzydowska; Aleksandra Pilszyk; Żaneta Kimber-Trojnar; Marcin Trojnar; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 10.  Adipokines and Inflammation: Focus on Cardiovascular Diseases.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Sandra Moraña-Fernández; Laura Anido-Varela; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Isabel Moscoso; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.